Рак простати Лікування в Велика Британія — Витрати 2026

UK prostate cancer treatment focuses on clinical surveillance, robotic surgery, and advanced radiotherapy. Specialists at centers like Harley Street Clinic utilize CyberKnife for precise tumor targeting. Treatment choice depends on cancer grade, patient age, and general fitness to ensure optimal functional outcomes.

• Active surveillance: Regular PSA tests and MRI scans monitor slow-growing, low-risk tumors.
• Robotic prostatectomy: Surgeons use da Vinci robotic systems to remove the prostate gland.
• Precision radiotherapy: Options include CyberKnife, Stereotactic Ablative Radiotherapy (SABR), and internal seed brachytherapy.
• Focal therapies: Targeted techniques like HIFU and NanoKnife treat specific areas of the prostate.

Bookimed Expert Insight: London clinics often lead in technology adoption before they reach wider regional availability. For example, Harley Street Clinic was the first UK facility to offer CyberKnife treatment. Patients seeking specific non-invasive options should prioritize London-based centers for faster access to these specialized robotic platforms.

Patient Consensus: Men note that surgery and radiation often provide similar survival results. Many emphasize discussing side effects like urinary control and sexual health with both urologists and oncologists before deciding.

Early-stage prostate cancer does not always require immediate treatment. Low-risk, slow-growing tumors often qualify for active surveillance. This monitoring strategy avoids unnecessary side effects from surgery or radiation. Specialists initiate treatment only if diagnostic tests show the cancer is progressing or becoming aggressive.

• Active surveillance: Regular PSA tests, multiparametric MRI, and biopsies monitor low-risk disease.
• Watchful waiting: Observation focuses on symptom management rather than a curative intent.
• Risk stratification: Gleason score and tumor volume determine if immediate intervention is necessary.
• UK technologies: Clinics like Harley Street Clinic offer CyberKnife for non-invasive treatment.

Bookimed Expert Insight: Patients in London have unique access to highly specialized partnerships for complex cases. Harley Street at University College Hospital combines private care with University College Hospital resources. This provides access to advanced clinical trials via the Sarah Cannon Research Institute. Such infrastructure is vital for patients transitioning from monitoring to active treatment protocols.

Patient Consensus: Patients emphasize that a Gleason 3+3 diagnosis provides time to research options without rushing. They note that active surveillance preserves daily quality of life by delaying potential surgical side effects.

Prostate cancer treatments in the UK commonly affect urinary, bowel, and sexual functions. Surgery often causes immediate urinary incontinence or erectile dysfunction. Radiation therapy may lead to gradual sexual changes and bowel irritation. Hormone therapy typically causes fatigue, hot flashes, and reduced bone density.

• Surgical recovery: Nerve-sparing techniques aim to preserve erectile function and bladder control.
• Radiation impact: CyberKnife and brachytherapy may cause temporary urinary urgency or fatigue.
• Hormonal changes: Androgen deprivation therapy often results in weight gain and mood shifts.
• Chemotherapy effects: Systemic treatments can cause nausea, hair loss, and increased infection risks.

Bookimed Expert Insight: Patients at London centers like Harley Street at University College Hospital benefit from integrated research partnerships. These collaborations often provide access to clinical trials focused on reducing treatment toxicity. Choosing facilities with the Macmillan Quality Environment Mark ensures a higher standard of supportive care during recovery.

Patient Consensus: Many patients find that fatigue lasts for weeks after radiation finishes. They also note that staying active helps manage the muscle loss caused by hormone therapy.

HIFU and focal therapy are available on the NHS for localized prostate cancer. Access depends on regional availability and specific clinical eligibility criteria. Centers like University College London Hospitals and Imperial College Healthcare provide these treatments. NICE guidelines require special consent and data collection.

• Regional availability: Specialist centers in London, Southampton, and Newcastle routinely offer focal treatments.
• Clinical eligibility: Patients must have localized cancer confirmed via multi-parametric MRI and biopsy.
• Treatment benefits: Focal therapy significantly reduces risks of incontinence and erectile dysfunction.
• Referral rights: You may request a referral to a specialist center if local hospitals lack HIFU.

Bookimed Expert Insight: While standard surgery or radiotherapy are often prioritized, centers like Harley Street at University College Hospital combine private and NHS expertise. Data shows that focal therapy costs around $16,000 to $28,000 privately. Choosing high-volume specialist centers ensures access to advanced techniques like NanoKnife or CyberKnife alongside traditional HIFU.

Patient Consensus: Patients emphasize that preserving quality of life is the primary reason for choosing focal therapy. They note that follow-up care requires long-term, intensive monitoring through regular PSA tests and MRI scans.

NHS prostate cancer treatment follows the 62-day urgent referral pathway. You should receive a diagnosis within 28 days of your GP referral. Treatment should ideally start within 62 days. However, complex cases may take significantly longer due to local trust capacity and staffing.

• Diagnostic target: Receive a definitive cancer diagnosis or ruling within 28 days of referral.
• Treatment target: First treatment should begin within 62 days of the initial urgent referral.
• Specialist reviews: Biopsies and Multidisciplinary Team reviews typically add several weeks to the timeline.
• Routine procedures: Non-emergency consultant-led elective treatments carry a legal right to start within 18 weeks.

Bookimed Expert Insight: Clinical urgency often dictates your schedule more than standard targets. While centers like Royal Brompton and Harefield NHS Foundation Trust manage high patient volumes, smaller trusts may face longer bottlenecks. Patients with high-risk Gleason scores or rapid PSA velocity typically move through the system faster than those with low-risk, slow-growing tumors.

Patient Consensus: Patients report that the journey from an initial PSA test to surgery can occasionally stretch to 7 or 10 months. Many suggest contacting the consultant’s secretary or PALS if the process feels stalled after the multidisciplinary team review.